Linezolid
Indication: Severe Gram-positive infections in critically ill patients, including COVID-19 ARDS on VV-ECMO
Interactive linezolid population PK simulator for critically ill COVID-19 ARDS patients on veno-venous ECMO. Linezolid is an oxazolidinone antibiotic that inhibits bacterial protein synthesis by binding the 50S ribosomal subunit. The model supports IV infusion exposure prediction and PK/PD target attainment assessment for severe Gram-positive infections.
Drug Overview
Clinical Context
- Molecular Target
- Bacterial 50S ribosomal subunit
- Drug Class
- Oxazolidinone antibiotic
- Therapeutic Area
- Infectious Disease / Critical Care
- Indication
- Severe Gram-positive infections in critically ill patients, including COVID-19 ARDS on VV-ECMO
- Route of Administration
- IV infusion
Model Information
- Model Type
- 1-compartment PopPK with IV infusion and PTA outputs
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Linezolid allows you to explore concentration-time profiles under different dosing scenarios. The underlying 1-compartment PopPK with IV infusion and PTA outputs model characterizes the pharmacokinetics of this oxazolidinone antibiotic following iv infusion administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Linezolid PK simulator?
This is a free, interactive pharmacokinetic simulator for Linezolid used in Severe Gram-positive infections in critically ill patients, including COVID-19 ARDS on VV-ECMO. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Linezolid belong to?
Linezolid is classified as a Oxazolidinone antibiotic that targets Bacterial 50S ribosomal subunit. It is used in the Infectious Disease / Critical Care therapeutic area.
What route of administration does this model simulate?
This simulator models IV infusion administration of Linezolid. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a 1-compartment PopPK with IV infusion and PTA outputs model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the Linezolid simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community